Media News

Cyient DLM Wins Long Term Deal with Honeywell Aerospace Technologies to Provide Aircraft Cooling Technology

HYDERABAD, India, Nov. 7, 2024 /PRNewswire/ -- Cyient DLM, an integrated partner for design-led manufacturing, announced its partnership with Honeywell Aerospace Technologies for the ground-breaking micro vapor cycle system (Micro VCS), aimed to revolutionize aircraft cooling technology. Cyient DLM has inked a 16-year program forecast to develop liquid cooling loops that will be used in select applications of Micro...

BRACCO TRIPLES PRODUCTION OF ITS INNOVATIVE CONTRAST AGENT FOR ULTRASOUND IN GENEVA, INAUGURATING A SECOND FACILITY

The significant investment increases the production of CEUS microbubbles The imaging platform for ultrasound, the fruit of Bracco's research, assists doctors all over the world with more accurate diagnostic data, improving patients' quality of life and facilitating personalized treatment plans PLAN-LES-OUATES, Switzerland, Nov. 6, 2024 /PRNewswire/ -- Over 80 million euros have...

CARsgen® to Present Zevor-cel, CT071 and CT0590 at ASH 2024 Annual Congress

SHANGHAI, Nov. 6, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the Company will present the clinical data of zevorcabtagene autoleucel, CT071, and CT0590 as posters at the 66th Annual Congress...

I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive Officer

ROCKVILLE, Md., Nov. 6, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a U.S.-based, global biotech company exclusively focused on the development of highly differentiated immunotherapies for the treatment of cancer, today announced that Sean (Xi-Yong) Fu, PhD, MBA has been appointed as the Company's permanent Chief Executive Officer ("CEO") effective November 1,...

MEGAROBO Unveils High-Content Cell Imaging System for Advanced Multidimensional Biological Analysis

BEIJING, Nov. 6, 2024 /PRNewswire/ -- MEGAROBO, a leading provider of advanced productivity tools for life sciences, has recently unveiled the CellVue™ T2000 high-content cell imaging system. The new cell imaging system is more than a digital microscope, featuring a high-sensitivity CMOS imaging camera that seamlessly integrates automated multi-color fluorescence imaging with quantitative data analysis. The system enables in-depth...

Dallah Hospital Al Nakheel Achieves Global Healthcare Accreditation, Reinforcing its Commitment to Excellence in Medical Travel

PALM BEACH GARDENS, Fla., Nov. 6, 2024 /PRNewswire/ -- Dallah Hospital Al Nakheel, a leading healthcare institution located in the heart of Riyadh, Saudi Arabia, is proud to announce its accreditation by Global Healthcare Accreditation (GHA) for Medical Travel Services. This prestigious recognition underscores the hospital's unwavering commitment to delivering exceptional care and services to both local and international...

Esaote Group expands production in India

Innovative series of ultrasound systems are now "Made in India" at the new manufacturing site of subsidiary Esaote Asia Pacific Diagnostic Private Limited in Uttar Pradesh NOIDA, India, Nov. 6, 2024 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic resonance imaging and information technology for...

CROWN AESTHETICS PROVIDES CAVENDISH CLINICS WITH AWARD-WINNING SKINPEN® PRECISION TO UPGRADE ITS MICRONEEDLING DEVICE OFFERING

LONDON, Nov. 6, 2024 /PRNewswire/ -- Crown Aesthetics, a Crown Laboratories company and leading innovator in the dermatologic and aesthetics industry, is proud to announce that Cavendish Clinics, one of the United Kingdom's ("UK") premier aesthetic clinic groups, has upgraded their microneedling devices to the award-winning SkinPen® Precision. This upgrade significantly...

ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma’s Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report

ROCKVILLE, Md. and SUZHOU, China, Nov. 6, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that the latest results from three clinical studies of one of the company's key drug candidate, lisaftoclax...

Hanmi Unveils Novel Obesity Drug ‘HM17321’ : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss

Fat Loss Augmentation + Lean Mass Increase Hanmi Presents Three Breakthrough Findings on Novel Obesity Drugs at 2024 ObesityWeekHigh Quality Obesity Management by Targeting the CRF2 Receptor: Enhanced Fat Loss with Lean Mass IncreaseImproved Weight Loss and Muscle Preservation with HM15275 Combination Therapy SEOUL, South Korea, Nov. 6, 2024 /PRNewswire/ -- Hanmi...